Prostate cancer detection percentages of repeat biopsy in patients with positive multiparametric magnetic resonance imaging (prostate imaging reporting and data …
N Grivas, M Lardas, EL Espinós, TB Lam, O Rouviere… - European Urology, 2022 - Elsevier
Multiparametric magnetic resonance imaging (mpMRI) has high sensitivity but low specificity
for prostate cancer (PCa) diagnosis. The aim of our systematic review was to investigate the …
for prostate cancer (PCa) diagnosis. The aim of our systematic review was to investigate the …
Transrectal Ultrasound in Prostate Cancer: Current Utilization, Integration with mpMRI, HIFU and Other Emerging Applications
J Panzone, T Byler, G Bratslavsky… - Cancer Management …, 2022 - Taylor & Francis
Transrectal ultrasound (TRUS) has been an invaluable tool in the assessment of prostate
size, anatomy and aiding in prostate cancer (PCa) diagnosis for decades. Emerging …
size, anatomy and aiding in prostate cancer (PCa) diagnosis for decades. Emerging …
Diagnostic performance of prostate-specific antigen density for detecting clinically significant prostate cancer in the era of magnetic resonance imaging: a systematic …
S Wang, J Kozarek, R Russell, M Drescher… - European Urology …, 2023 - Elsevier
Context There has been a dramatic increase in the use of prostate magnetic resonance
imaging (MRI) in the diagnostic workup. With prostate volume calculated from MRI, prostate …
imaging (MRI) in the diagnostic workup. With prostate volume calculated from MRI, prostate …
Follow-up of men with a PI-RADS 4/5 lesion after negative MRI/Ultrasound fusion biopsy
K Kornienko, M Reuter, A Maxeiner, K Günzel… - Scientific Reports, 2022 - nature.com
Magnetic resonance imaging/Ultrasound (MRI/US) fusion targeted biopsy (TB) in
combination with a systematic biopsy (SB) improves cancer detection but limited data is …
combination with a systematic biopsy (SB) improves cancer detection but limited data is …
Development of an effective predictive screening tool for prostate cancer using the ClarityDX machine learning platform
ME Hyndman, RJ Paproski, A Kinnaird, A Fairey… - npj Digital …, 2024 - nature.com
The current prostate cancer (PCa) screen test, prostate-specific antigen (PSA), has a high
sensitivity for PCa but low specificity for high-risk, clinically significant PCa (csPCa), resulting …
sensitivity for PCa but low specificity for high-risk, clinically significant PCa (csPCa), resulting …
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single …
Objective We aimed at optimizing the follow-up for patients with a positive multiparametric
magnetic resonance of the prostate (mpMRI) and a subsequent negative targeted biopsy …
magnetic resonance of the prostate (mpMRI) and a subsequent negative targeted biopsy …
[HTML][HTML] Magnetic resonance imaging follow-up of targeted biopsy–negative prostate lesions
V Stavrinides, E Eksi, R Finn, L Texeira-Mendes… - European Urology …, 2023 - Elsevier
Background The optimal radiological follow-up of prostate lesions negative on magnetic
resonance imaging (MRI)-targeted biopsy (MRI-TB) is yet to be optimised. Objective To …
resonance imaging (MRI)-targeted biopsy (MRI-TB) is yet to be optimised. Objective To …
Detection rate of prostate cancer in repeat biopsy after an initial negative magnetic resonance imaging/ultrasound-guided biopsy
M Görtz, AK Huber, T Linz, C Schwab, A Stenzinger… - Diagnostics, 2023 - mdpi.com
A negative multiparametric magnetic resonance imaging (mpMRI)-guided prostate biopsy in
patients with suspected prostate cancer (PC) results in clinical uncertainty, as the biopsy can …
patients with suspected prostate cancer (PC) results in clinical uncertainty, as the biopsy can …
Synthesis and preclinical evaluation of 68Ga-labeled PSMA tracers with improved pharmacological properties
H Hou, Y Lin, Y Pan, Y Ma, G Hou, X Sun… - European Journal of …, 2024 - Elsevier
Prostate cancer (PCa) is one of the most common tumors in men, with the overexpression of
prostate-specific membrane. In this study, we developed four new 68 Ga-labeled PSMA …
prostate-specific membrane. In this study, we developed four new 68 Ga-labeled PSMA …
Incidence of significant prostate cancer after negative MRI and systematic biopsy in the FUTURE trial
L Exterkate, O Wegelin, JO Barentsz… - BJU …, 2023 - Wiley Online Library
Objectives To assess the proportion of clinically significant (cs) prostate cancer (PCa) found
during follow‐up in patients with negative systematic biopsy (SB) followed by non …
during follow‐up in patients with negative systematic biopsy (SB) followed by non …